AstraZeneca Acquires Amolyt Pharma for $1.05B, Expanding Rare-Disease Portfolio
Drugmaker AstraZeneca said on Thursday it would acquire rare endocrine diseases-focused firm Amolyt Pharma for $1.05 billion in cash, in…
Drugmaker AstraZeneca said on Thursday it would acquire rare endocrine diseases-focused firm Amolyt Pharma for $1.05 billion in cash, in…
Responding to a U.S. government audit, Boeing said Tuesday that it would work with employees found to have violated company…
German sportswear giant Adidas posted its first annual loss in more than 30 years on Wednesday and warned sales in…
The Tensor Foundation, a recently formed organization behind Solana-based NFT marketplace Tensor, has outlined its plans for the TNSR token.…
Xiaomi Corp.’s shares had their biggest intraday jump in more than a year after the company announced it will start…
Reddit Inc. disclosed further details of what is set to be one of the year’s biggest initial public offerings, with…
Oracle Corp. surged 13% after reporting a spike in bookings attributed to its closely watched cloud computing business, showing progress…
Oil pushed lower ahead of US inflation data and reports from OPEC and the IEA this week that may provide…
Volkswagen Australia said on Monday it had quit the policymaking committee at the country’s auto lobby, days after Tesla cut…
The European Commission’s use of Microsoft software breached EU privacy rules and the bloc’s executive also failed to implement adequate…
[mstock id=”66″]